Colllege of Pharmacy News Feed from Purdue University News Service
Updated: 1 hour 31 min ago
What are the limitations of the disease model of addiction and what are its benefits? How does this affect our understanding of the roots of the opioid crisis and potential remedies?
A leading neuroscientist will discuss recent advances in genome editing technologies, addressing the question of “What IF Breakthrough Technologies Could Make Us Smarter?” during an Oct. 15 event at Purdue University.
The head of one of the institutes within the National Institutes of Health will share experiences and insights in an Oct. 2 presentation at Purdue University.
In 1944, people in The Netherlands entered into what would become known as the Hongerwinter, or hunger winter, a famine created in retribution by the Nazis for resistance activities in the German-occupied nation near the end of World War II.
'They got all of it' are the reassuring words people hope to hear following cancer surgery, but a growing understanding of the science of how cancer spreads, and metastasizes, is suggesting that not only is this almost never true but — and here is the surprising part — it might be better to try to contain the cancer than to eliminate it.
A deadly meningitis outbreak linked to a Massachusetts pharmaceutical lab has drawn new interest to the way drugs are made in the United States and the training for those who work in pharmacies.
Helping people with addictions has become a research passion for Purdue University’s Richard van Rijn, who is leading a team to make drug discoveries to support millions around the world dealing with alcohol use disorders, chronic pain and mood disorders.
Purdue University students and faculty have joined the fight against the state’s opioid crisis.
A multidisciplinary team of researchers at Purdue University and the University of Bordeaux in France has received a grant from The Michael J. Fox Foundation for Parkinson’s Disease to study a new gene associated with Parkinson’s disease, which was linked to the disease using novel big data methodologies.
A Purdue alumna and her husband have donated an additional $8 million to their Pacesetter Endowment for Pharmacy, which provides student scholarships and ultimately will support renovation, expansion or a new facility for the College of Pharmacy.
A molecule has been identified that appears to play an important role in the development of Parkinson's disease, a debilitating disease that affects millions of people around the world.
Purdue University is hosting its first Team Life Science Week in celebration of the vibrant life science community on campus. Lectures, tours, gallery receptions and more will take place on campus Monday (March 19) through Friday (March 23).
Indiana Gov. Eric Holcomb has named October as American Pharmacist Month in Indiana, thanks to a little push from two Purdue University students.
Purdue University trustees on Friday (June 16) approved a new bachelor’s degree in biochemistry at the Fort Wayne campus, approved three distinguished and named professorships, and honored several university administrators and donors with resolutions of appreciation.
The fourth annual North Central Indiana Area Health Education Center Discover Healthcare summer program will take place June 5 and 6 at Purdue University.
Purdue researchers have discovered a compound that could lead to the treatment of chronic pain without the need for patients to rely on opioids.
Eric L. Barker will become dean of Purdue University’s College of Pharmacy, effective July 1, 2017. Barker is a professor of medicinal chemistry and molecular pharmacology and has served as associate dean for research in Purdue’s College of Pharmacy since 2010.
Purdue University alumnus Allen Chao, who co-founded Watson Pharmaceuticals in 1983 and has had a long distinguished career in pharmaceutical research and development, is bringing his expertise to the Purdue GMP Center LLC in the Purdue Research Park of West Lafayette.
Eight Purdue University professors have been awarded the distinction of fellow from the American Association for the Advancement of Science, the world's largest general scientific society.
A newly published study has shown that an antiviral drug commonly used to treat HIV can cause heart abnormalities in people who have a genetic mutation in the enzyme that metabolizes the medication, potentially leading to sudden cardiac death.